Vaccination Campaign

Malaysia's Covid-19 Vaccine Portfolio

As of February 2021, Malaysia has secured 66.7 million doeses of Covid-19 vaccines through COVAX Facility and purchases from five vaccine manufacturers. Among all five vaccine manufacturers, the Pfizer-BioNTech vaccine has required conditional approval from the Drug Control Authority (DCA) and the National Pharmaceutical Regulatory Agency (NPRA) as on 8th January 2021. The remaining four Covid-19 vaccine candidates are still in pending approval list from NPRA. The supply of vaccines from these five vaccines suppliers will be received accordingly in stages in Malaysia starting February 2021, as of NPRA approval.

Supply of Covid19 vaccines Malaysia's acquired

Logo	Vaccine	Types of vaccines	Manufacturer's country	Number of doses	Efficacy	Storage temperature	Number of doses (Million)	% of populations	Countries that have used the vaccine
	Pfizer	mRNA	United States of America	2	95%	-75°C	32	50%	United States of America (USA), America, Singapore, United Kingdom (UK), Canaa, Mexico, Switzerland and the European Union
	AstraZeneca	Viral vector	United Kingdom	2	62%-90%	2-8°C	12.8	20%	United Kingdom (UK), South Africa, Ukraine, Brazil, European Union, Canada, India
	Sinovac	Inactivated virus	China	2	50.4%-91.25%	2-8°C	12	18.75%	China, Indonesia, Turkey, Chile, Hong Kong, Brazil, Cambodia
	CanSinoBIO	Viral vector	China	1	65.7%	2-8°C	3.5	10.9%	China, Mexico, Paksitan
	S:putnik V	Viral vector	Russia	2	91.6%	-20°C	6.4	10%	Russia, Argentina, Brazil, Belarus